Close Close

Portfolio > Asset Managers

Invesco Fires Next Shot in Fee War With Funds Charging Nothing (for Now)

Your article was successfully shared with the contacts you provided.

Invesco Ltd. launched two new exchange-traded funds Friday with management costs waived until the end of the year, further escalating the ETF industry’s long-running fee war.

The Invesco Nasdaq Biotechnology ETF (IBBQ) and Invesco PHLX Semiconductor ETF (SOXQ) will effectively cost nothing until Dec. 17, after which each will carry an expense ratio of 19 basis points, according to a press release from the firm.

Issuers across the $6.4 trillion ETF industry have been battling to have the lowest cost offerings for years in a bid to capture assets as the total number of funds surpasses 2,400.

Earlier this year, State Street Global Advisors slashed fees on its two of its bond ETFs a day after BlackRock Inc. made a similar move.

Still, a zero expense ratio — even for a limited period of time — is relatively uncommon.

BNY Mellon Investment Management released the first zero-fee bond fund last year as well as another zero-fee product tracking big American companies. But so far no other large asset managers have made comparable moves.

The IBBQ fund will provide exposure to about 270 innovative biotechnology companies, including some that helped with Covid-19 vaccines and treatments.

Meanwhile, SOXQ will include 30 of the largest names in the semiconductor industry.

Invesco has about $343 billion in ETF assets, comprising roughly 5.5% of the total U.S. market, according to data compiled by Bloomberg.


Copyright 2021 Bloomberg. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.